menu
    • menu

    Company profile for Medigen Vaccine Biologics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Medigen Biotechnology Corp. (MBC) was established in late 1999. The company upholds the vision of “Innovations for a better life” focusing on the development of new therapies for liver diseases and cancers. MBC has now gradually developed into a comprehensive biopharmaceutical corporation with business fields covering new drug development, innovative drug discovery, molecular diagnostics, vaccine, and generic drugs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Medigen Vaccine BiologicsTaiwan Flag
    Country
    Country
    Taiwan
    Address
    Address
    14F. No.3, Park St., Nangang Dist., Taipei City 11503, Taiwan
    Telephone
    Telephone
    +886-2-7736-1234
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.medigen.com.tw/en/home/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BlueWillow, MVC Show Positive Results for Intranasal COVID-19 Booster Candidate
    BlueWillow, MVC Show Positive Results for Intranasal COVID-19 Booster Candidate

    02 Mar 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220302005134/en

    BUSINESSWIRE
    02 Mar 2022
    Share Share
    Medigen is Granted Provisional Determination by TGA
    Medigen is Granted Provisional Determination by TGA

    22 Nov 2021

    // TGA

    https://www.tga.gov.au/tga-grants-provisional-determination-grand-pacific-cro-australia-behalf-medigen-vaccine-biologics-corp-its-covid-19-protein-based-subunit-vaccine

    TGA
    22 Nov 2021
    Share Share
    Medigen Vaccine Biologics Announces Launch of Its COVID-19 Vaccine
    Medigen Vaccine Biologics Announces Launch of Its COVID-19 Vaccine

    23 Aug 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/medigen-vaccine-biologics-announces-launch-of-its-covid-19-vaccine-mvc-cov1901-adjuvanted-with-dynavaxs-cpg-1018-adjuvant-301360276.html

    PRNEWSWIRE
    23 Aug 2021
    Share Share
    Taiwan's Medigen to start late-stage trial for COVID-19 vaccine in Paraguay
    Taiwan's Medigen to start late-stage trial for COVID-19 vaccine in Paraguay

    20 Jul 2021

    // REUTERS

    https://www.reuters.com/article/us-health-coronavirus-taiwan-vaccine/taiwans-medigen-to-start-late-stage-clinical-trial-for-covid-19-vaccine-in-paraguay-idUSKBN2EQ0TI

    REUTERS
    20 Jul 2021
    Share Share
    Taiwan approves Medigen's COVID-19 vaccine candidate
    Taiwan approves Medigen's COVID-19 vaccine candidate

    19 Jul 2021

    // REUTERS

    https://www.reuters.com/article/us-health-coronavirus-taiwan-vaccine/taiwan-approves-medigens-covid-19-vaccine-candidate-idUSKBN2EP0E5

    REUTERS
    19 Jul 2021
    Share Share
    Medigen Vaccine Biologics initiates Ph 2 trial of COVID-19 vaccine in Taiwan
    Medigen Vaccine Biologics initiates Ph 2 trial of COVID-19 vaccine in Taiwan

    29 Jan 2021

    // BIOSPECTRUMASIA

    https://www.biospectrumasia.com/news/37/17496/medigen-vaccine-biologics-initiates-ph-2-trial-of-covid-19-vaccine-in-taiwan.html

    BIOSPECTRUMASIA
    29 Jan 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search